[Tokyo, Japan] – [March 6th, 2025 – infuse Life Sciences, Inc. today announced it has been selected for another grant from the Tokyo Metropolitan Small and Medium Enterprise Support Center. This grant will support the company’s development of a groundbreaking new treatment in the field of gynecology. This marks the second pipeline advancement for the company, following the recent announcement of its innovative diagnostic technology.

This novel treatment aims to address the long-standing lack of innovation in gynecological standard care. infuse Life Sciences will leverage this grant funding to expedite research and development efforts, with the goal of bringing this potentially transformative therapy to patients as quickly as possible.

CEO Saito's Statement:

"We are honored to receive this grant, which recognizes our research and development capabilities and innovative spirit. The field of gynecology has seen limited innovation for many years, and we are committed to being a catalyst for change. We believe this new treatment has the potential to significantly improve the standard of care and benefit countless patients."

About Infuse Life Sciences:

Founded in December 2024, Infuse Life Sciences is a medical device company focused on developing innovative diagnostic and therapeutic solutions for women's health.